In addition, our current study revealed that QDG treatment not only attenuated the elevation of blood pressure but also significantly reduced Ang II-induced renal pathological changes, suggesting that QDG might be used as a complementary therapy to attenuate hypertension and prevent hypertensive target organ injury (including renal injury). The gene discussed is AGT; the disease is Hypertension.